Effect of a Prodrug of the Green Tea Polyphenol (-)-Epigallocatechin-3-Gallate on the Growth of Androgen-Independent Prostate Cancer In Vivo

REFERENCES

• Penson , D F and Albertsen , P C . 2002 . Lessons learnt about early prostate cancer from large scale databases: population based pearls of wisdom . Surg Oncol , 11 : 3 – 11 .
   PubMedGoogle Scholar
• Pienta , K J and Smith , D C . 2005 . Advances in prostate cancer chemotherapy: a new era begins . CA Cancer J Clin , 55 : 300 – 318 .
   PubMedGoogle Scholar
• Silvestris , N , Leone , B , Numico , G , Lorusso , V and De Lena , M . 2005 . Present status and perspectives in the treatment of hormone-refractory prostate cancer . Oncology , 69 : 273 – 283 .
   PubMedGoogle Scholar
• Stewart , B and Kleihues , P . 2003 . World Cancer Report, International Agency for Research on Cancer , Geneva, , Switzerland : World Health Organization .
   Google Scholar
• Adami , H-O , Hunter , D J and Trichopoulos , D , eds. 2002 . Textbook of cancer epidemiology , 402 New York : Oxford University Press .
   Google Scholar
• Sonoda , T , Nagata , Y , Mori , M , Miyanaga , N Takashima , N . 2004 . A case-control study of diet and prostate cancer in Japan: possible protective effect of traditional Japanese diet . Cancer Sci , 95 : 238 – 242 .
   PubMed Web of Science ®Google Scholar
• Jian , L , Xie , L P , Lee , A H and Binns , C W . 2004 . Protective effect of green tea against prostate cancer: a case-control study in southeast China . Int J Cancer , 108 : 130 – 135 .
   PubMed Web of Science ®Google Scholar
• Adhami , V M , Ahmad , N and Mukhtar , H . 2003 . Molecular targets for green tea in prostate cancer prevention . J Nutr , 133 : 2417S – 2424S .
   PubMed Web of Science ®Google Scholar
• Chen , D , Daniel , K G , Kuhn , D J , Kazi , A Bhuiyan , M . 2004 . Green tea and tea polyphenols in cancer prevention . Front Biosci , 9 : 2618 – 2631 .
   PubMedGoogle Scholar
• Paschka , A G , Butler , R and Young , C Y . 1998 . Induction of apoptosis in prostate cancer cell lines by the green tea component, (-)-epigallocatechin-3-gallate . Cancer Lett , 130 : 1 – 7 .
   PubMed Web of Science ®Google Scholar
• Klein , E A . 2005 . Chemoprevention of prostate cancer . Crit Rev Oncol Hematol , 54 : 1 – 10 .
   PubMed Web of Science ®Google Scholar
• Hussain , T , Gupta , S , Adhami , V M and Mukhtar , H . 2005 . Green tea constituent epigallocatechin-3-gallate selectively inhibits COX-2 without affecting COX-1 expression in human prostate carcinoma cells . Int J Cancer , 113 : 660 – 669 .
   PubMed Web of Science ®Google Scholar
• Sonn , G A , Aronson , W and Litwin , M S . 2005 . Impact of diet on prostate cancer: a review . Prostate Cancer Prostatic Dis , 8 : 304 – 310 .
   PubMed Web of Science ®Google Scholar
• Gupta , S , Hastak , K , Ahmed , N , Lewin , J S and Mukhtar , H . 2001 . Inhibition of prostate carcinogenesis in TRAMP mice by oral infusion of green tea polyphenols . Proc Nat Acad Sci USA , 98 : 10350 – 10355 .
   PubMed Web of Science ®Google Scholar
• Jatoi , A , Ellison , N , Burch , P A , Sloan , J A Dakhil , S R . 2003 . A phase II trial of green tea in the treatment of patients with androgen independent metastatic prostate carcinoma . Cancer , 97 : 1442 – 1446 .
   PubMed Web of Science ®Google Scholar
• Chen , Z , Zhu , Q Y , Tsang , D and Huang , Y . 2001 . Degradation of green tea catechins in tea drinks . J Agric Food Chem , 49 : 477 – 482 .
   PubMed Web of Science ®Google Scholar
• Lam , W H , Kazi , A , Kuhn , D J , Chow , L M Chan , A S . 2004 . A potential prodrug for a green tea polyphenol proteasome inhibitor: evaluation of the peracetate ester of (-)-epigallocatechin gallate [(-)-EGCG] . Bioorg Med Chem , 12 : 5587 – 5593 .
   PubMed Web of Science ®Google Scholar
• Lu , H , Meng , X and Yang , C S . 2003 . Enzymology of methylation of tea catechins and inhibition of catechol-O-methyltransferase by (-)-epigallocatechin gallate . Drug Metab Dispos , 31 : 572 – 579 .
   PubMed Web of Science ®Google Scholar
• Sang , S , Lambert , J D and Yang , C S . 2006 . Bioavailability and stability issues in understanding the cancer preventive effects of tea polyphenols . J Sci Food Agric , 86 : 2256 – 2265 .
   Web of Science ®Google Scholar
• Lambert , J D and Yang , C S . 2003 . Cancer chemopreventive activity and bioavailability of tea and tea polyphenols . Mutat Res , 523–524 : 201 – 208 .
   PubMed Web of Science ®Google Scholar
• Lambert , J D , Sang , S , Hong , J , Kwon , S J Lee , M J . 2006 . Peracetylation as a means of enhancing in vitro bioactivity and bioavailability of epigallocatechin-3-gallate . Drug Metab Dispos , 34 : 2111 – 2116 .
   PubMed Web of Science ®Google Scholar
• Kuhn , D , Lam , W H , Kazi , A , Daniel , K G Song , S . 2005 . Synthetic peracetate tea polyphenols as potent proteasome inhibitors and apoptosis inducers in human cancer cells . Front Biosci , 10 : 1010 – 1023 .
   PubMed Web of Science ®Google Scholar
• Nagabhushan , M , Miller , C M , Pretlow , T P , Giaconia , J M Edgehouse , N L . 1996 . CWR22: the first human prostate cancer xenograft with strongly androgen-dependent and relapsed strains both in vivo and in soft agar . Cancer Res , 56 : 3042 – 3046 .
   PubMed Web of Science ®Google Scholar
• Nakashiro , K , Hara , S , Shinohara , Y , Oyasu , M Kawamata , H . 2004 . Phenotypic switch from paracrine to autocrine role of hepatocyte growth factor in an androgen-independent human prostatic carcinoma cell line, CWR22R . Am J Pathol , 165 : 533 – 540 .
   PubMedGoogle Scholar
• Tepper , C G , Boucher , D L , Ryan , P E , Ma , A H Xia , L . 2002 . Characterization of a novel androgen receptor mutation in a relapsed CWR22 prostate cancer xenograft and cell line . Cancer Res , 62 : 6606 – 6614 .
   PubMed Web of Science ®Google Scholar
• Chlenski , A , Nakashiro , K , Ketels , K V , Korovaitseva , G I and Oyasu , R . 2001 . Androgen receptor expression in androgen-independent prostate cancer cell lines . Prostate , 47 : 66 – 75 .
   PubMed Web of Science ®Google Scholar
• Hastak , K , Agarwal , M K , Mukhtar , H and Agarwal , M L . 2005 . Ablation of either p21 or Bax prevents p53-dependent apoptosis induced by green tea polyphenol epigallocatechin-3-gallate . FASEB J , 19 : 789 – 791 .
   PubMed Web of Science ®Google Scholar
• Gupta , S , Hastak , K , Afaq , F , Ahmad , N and Mukhtar , H . 2004 . Essential role of caspases in epigallocatechin-3-gallate-mediated inhibition of nuclear factor kappa B and induction of apoptosis . Oncogene , 23 : 2507 – 2522 .
   PubMed Web of Science ®Google Scholar
• Hastak , K , Gupta , S , Ahmad , N , Agarwal , M K Agarwal , M L . 2003 . Role of p53 and NF-kappaB in epigallocatechin-3-gallate-induced apoptosis of LNCaP cells . Oncogene , 22 : 4851 – 4859 .
   PubMed Web of Science ®Google Scholar
• Folkman , J . 1992 . The role of angiogenesis in tumor growth . Semin Cancer Biol , 3 : 65 – 71 .
   PubMedGoogle Scholar
• Compagni , A and Christofori , G . 2000 . Recent advances in research on multistage tumorigenesis . Br J Cancer , 83 : 1 – 5 .
   PubMed Web of Science ®Google Scholar
• Hanahan , D and Weinberg , R A . 2000 . The hallmarks of cancer . Cell , 100 : 57 – 70 .
   PubMed Web of Science ®Google Scholar
• Hayward , S W , Grossfeld , G D , Tlsty , T D and Cunha , G R . 1998 . Genetic and epigenetic influences in prostatic carcinogenesis . Int J Oncol , 13 : 35 – 47 .
   PubMedGoogle Scholar
• Taftachi , R , Ayhan , A , Ekici , S , Ergen , A and Ozen , H . 2005 . Proliferating-cell nuclear antigen (PCNA) as an independent prognostic marker in patients after prostatectomy: a comparison of PCNA and Ki-67 . BJU Int , 95 : 650 – 654 .
   PubMed Web of Science ®Google Scholar
• Bono , A V , Celato , N , Cova , V , Salvadore , M Chinetti , S . 2002 . Microvessel density in prostate carcinoma . Prostate Cancer Prostatic Dis , 5 : 123 – 127 .
   PubMedGoogle Scholar
• Landis-Piwowar , K R , Huo , G , Chen , D , Milacic , V Shi , G . 2007 . A novel prodrug of the green tea polyphenol (-)-EGCG as a potential anticancer agent . Cancer Res , 67 : 4303 – 4310 .
   PubMed Web of Science ®Google Scholar